List of bibliographic references
Number of relevant bibliographic references: 20.
| Ident. | Authors (with country if any) | Title |
|---|
| 000878 (2012) |
O. Rascol ; J. Bronzova ; R A Hauser ; A E Lang ; C. Sampaio ; A. Theeuwes ; S V Van De Witte | Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. |
| 000A05 (2011) |
Sylvia Navailles ; Bernard Bioulac ; Christian Gross ; Philippe De Deurwaerdère | Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease. |
| 000A34 (2010) |
Olivier Rascol ; Paolo Barone ; Robert A. Hauser ; Yoshikuni Mizuno ; Werner Poewe ; Anthony H V. Schapira ; Laurence Salin ; Mandy Sohr ; Catherine Debieuvre | Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. |
| 000D06 (2008) |
Erwan Bezard | [Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure]. |
| 000D35 (2007) |
G. Villafane ; P. Cesaro ; A. Rialland ; S. Baloul ; S. Azimi ; C. Bourdet ; J. Le Houezec ; I. Macquin-Mavier ; P. Maison | Chronic high dose transdermal nicotine in Parkinson's disease: an open trial. |
| 000F59 (????) |
O. Rascol ; D J Brooks ; E. Melamed ; W. Oertel ; W. Poewe ; F. Stocchi ; E. Tolosa | Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. |
| 001001 (2004) |
S. Robelet ; C. Melon ; B. Guillet ; P. Salin ; L. Kerkerian-Le Goff | Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease. |
| 001112 (2003) |
Marc Ziegler ; Alexandre Castro-Caldas ; Susanna Del Signore ; Olivier Rascol | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study. |
| 001118 (2003) |
Olivier Rascol | Monoamine oxidase inhibitors--is it time to up the TEMPO? |
| 001129 (2003) |
Olivier Rascol ; C. Brefel-Courbon ; P. Payoux ; J. Ferreira | The management of patients with early Parkinson's disease. |
| 001139 (2003) |
S. Thobois ; S. Corvaisier ; P. Mertens ; C. Di Guardo ; H. Mollion ; M. Guenot ; F. Rochefort ; G. Chazot ; M. Sindou ; E. Broussolle | The timing of antiparkinsonian treatment reduction after subthalamic nucleus stimulation. |
| 001143 (2003) |
H. Mollion ; J. Ventre-Dominey ; P F Dominey ; E. Broussolle | Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease. |
| 001180 (2002) |
Aïcha Douhou ; Thomas Debeir ; Mario Gustavo Murer ; Louis Do ; Noëlle Dufour ; Véronique Blanchard ; Saliha Moussaoui ; Georg Andrees Bohme ; Yves Agid ; Rita Raisman-Vozari | Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice. |
| 001270 (2001) |
F. Durif ; I. Devaux ; J J Pere ; J C Delumeau ; I. Bourdeix | Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study. |
| 001367 (1999) |
Y. Agid ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; W. Poewe ; P. Pollak ; E. Tolosa | Levodopa in the treatment of Parkinson's disease: a consensus meeting. |
| 001503 (1997) |
E. Bezard ; S. Dovero ; B. Bioulac ; C. Gross | Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. |
| 001627 (1995) |
P. Limousin ; P. Pollak ; J P Pfefen ; C L Tournier-Gervason ; R. Dubuis ; J E Perret | Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, Parkinson's disease. |
| 001694 (1994) |
R. Marconi ; D. Lefebvre-Caparros ; A M Bonnet ; M. Vidailhet ; B. Dubois ; Y. Agid | Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. |
| 001740 (1993) |
E. Nicolle ; P. Pollak ; F. Serre-Debeauvais ; P. Richard ; C L Gervason ; E. Broussolle ; M. Gavend | Pharmacokinetics of apomorphine in parkinsonian patients. |
| 001764 (1992) |
A P Feve ; N. Bathien ; P. Rondot | Chronic administration of L-dopa affects the movement-related cortical potentials of patients with Parkinson's disease. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Drug Administration Schedule"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i \
-Sk "Drug Administration Schedule" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Corpus
|type= indexItem
|index= MedMesh.i
|clé= Drug Administration Schedule
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
